Target intelligence / Profile preview

Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1)

Target
MKP-1
Molecular classification
Enzyme, Phosphatase, Dual-Specificity Phosphatase
01

Overview

MAP kinase phosphatase 1 (MKP-1), also known as dual-specificity phosphatase 1 (DUSP1), is a nuclear-localized, inducible enzyme that plays a critical role in the negative regulation of mitogen-activated protein kinase (MAPK) signaling pathways. MKP-1 is the founding member of the MAPK phosphatases family and acts as an immediate-early gene product, rapidly induced by various cellular stresses and stimuli such as oxidative stress, growth factors, cytokines, fatty acids, glucocorticoids, hypoxia, and UV radiation. MKP‑1 functions as a dual-specificity phosphatase that dephosphorylates both threonine and tyrosine residues on activated MAPKs. This action inactivates key kinases including ERK (extracellular signal-regulated kinases), JNKs (c-Jun N-terminal kinases), and p38 MAPKs—though substrate preference can vary by cell type or context. By doing so, it provides negative feedback control over MAPK signaling cascades and regulates processes such as gene expression, cell proliferation/differentiation/survival/death responses to stressors. Given its central role in controlling inflammation/metabolism via modulation of MAPK activity, dysregulation contributes to chronic inflammatory diseases/metabolic syndromes, making it a potential therapeutic target for modulating immune responses or treating metabolic disorders.

Other names
DUSP1
02

Mechanism of action

Dephosphorylation of threonine and tyrosine residues on MAP kinases (ERKs, JNKs, p38)

03

Biological functions

Signal transductionNegative regulation of MAPK signalingRegulation of gene expressionRegulation of cell proliferationRegulation of cell differentiationRegulation of cell survivalRegulation of cell deathImmune responseMetabolic homeostasis
04

Disease associations

InflammationMetabolic disordersChronic inflammatory diseasesMetabolic syndromesSarcopeniaObesityDiabetesEndotoxic shockSeptic shock
05

Safety considerations

Modulation of immune responses may have unintended consequences.Dysregulation contributes to chronic inflammatory diseases/metabolic syndromes.

Beyond the preview

Go deeper on Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-Activated Protein Kinase Phosphatase 1 (MKP-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call